During the recent session, Oscar Health Inc (NYSE:OSCR)’s traded shares were 0.55 million, with the beta value of the company hitting 1.75. At the last check today, the stock’s price was $13.68, reflecting an intraday gain of 1.47% or $0.2. The 52-week high for the OSCR share is $23.79, that puts it down -73.9 from that peak though still a striking 9.14% gain since the share price plummeted to a 52-week low of $12.43. The company’s market capitalization is $3.43B, and the average intraday trading volume over the past 10 days was 3.66 million shares, and the average trade volume was 4.59 million shares over the past three months.
Oscar Health Inc (OSCR) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 2.62. OSCR has a Sell rating from 0 analyst(s) out of 5 analysts who have looked at this stock. 2 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 3 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be 0.81.
Oscar Health Inc (NYSE:OSCR) trade information
Oscar Health Inc (OSCR) registered a 1.47% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 1.47% in intraday trading to $13.68, hitting a weekly high. The stock’s 5-day price performance is 4.89%, and it has moved by -7.52% in 30 days. Based on these gigs, the overall price performance for the year is -2.02%. The short interest in Oscar Health Inc (NYSE:OSCR) is 21.13 million shares and it means that shorts have 3.48 day(s) to cover.
The consensus price target of analysts on Wall Street is $21, which implies an increase of 34.86% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $5 and $28 respectively. As a result, OSCR is trading at a discount of -104.68% off the target high and 63.45% off the low.
Oscar Health Inc (OSCR) estimates and forecasts
In the rating firms’ projections, revenue will increase 21.66% compared to the previous financial year.
As companies strive to predict their financial trajectories, we turn our attention to the forthcoming financial quarter. Here are the insights gathered from industry analysts. Revenue for the current quarter is expected to be 2.87B as predicted by 7 analyst(s). Meanwhile, a consensus of 7 analyst(s) estimates revenue growth to 2.78B by the end of current fiscal year. As per earnings report from last fiscal year’s results, sales for the corresponding quarters totaled 2.14B and 2.22B respectively. In this case, analysts expect current quarter sales to grow by 33.75% and then jump by 25.19% in the coming quarter.
OSCR Dividends
Oscar Health Inc is due to release its next quarterly earnings on 2025-Feb-03. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Oscar Health Inc (NYSE:OSCR)’s Major holders
Oscar Health Inc insiders own 3.32% of total outstanding shares while institutional holders control 92.14%, with the float percentage being 95.30%. VANGUARD GROUP INC is the largest shareholder of the company, while 360.0 institutions own stock in it. As of 2024-06-30, the company held over 17.38 million shares (or 7.5114% of all shares), a total value of $275.03 million in shares.
The next largest institutional holding, with 14.18 million shares, is of BLACKROCK INC.’s that is approximately 5.9391% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $224.25 million.
Also, the Mutual Funds coming in first place with the largest holdings of Oscar Health Inc (OSCR) shares are VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and SMALLCAP WORLD FUND INC. Data provided on Dec 31, 2024 indicates that VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund owns about 6.14 shares. This amounts to just over 2.85 percent of the company’s overall shares, with a $83.54 million market value. The same data shows that the other fund manager holds slightly less at 5.25, or about 2.44% of the stock, which is worth about $71.41 million.
